Half-year report · Q2
7363.TEDINET S100YNPB
Period2025-01-01 → 2025-06-30
Filed2026-06-30
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Amends S100WJ8A. Amended by S100YNPQ (2026-06-30).
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥920m | 2025-01-01 → 2025-06-30 | Standalone | Net sales |
| Revenue | ¥1.5bn | 2024-01-01 → 2024-12-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥735m | 2024-01-01 → 2024-06-30 | Standalone | Net sales |
| Operating income | ¥100m | 2025-01-01 → 2025-06-30 | Standalone | Operating income |
| Operating income | ¥29m | 2024-01-01 → 2024-06-30 | Standalone | Operating income |
| Ordinary income | ¥96m | 2025-01-01 → 2025-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥44m | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥29m | 2024-01-01 → 2024-06-30 | Standalone | Ordinary income |
| Profit before tax | ¥96m | 2025-01-01 → 2025-06-30 | Standalone | Income before income taxes |
| Profit before tax | ¥21m | 2024-01-01 → 2024-06-30 | Standalone | Income before income taxes |
| Net income | ¥59m | 2025-01-01 → 2025-06-30 | Standalone | Profit loss |
| Net income | −¥16m | 2024-01-01 → 2024-12-31 | Standalone | Net income loss (5-year summary) |
| Net income | ¥17m | 2024-01-01 → 2024-06-30 | Standalone | Profit loss |
| Total assets | ¥1.5bn | at 2025-06-30 | Standalone | Assets |
| Total assets | ¥1.5bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥967m | at 2024-06-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥756m | at 2025-06-30 | Standalone | Liabilities |
| Total liabilities | ¥854m | at 2024-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥734m | at 2025-06-30 | Standalone | Net assets |
| Net assets / equity | ¥672m | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥681m | at 2024-06-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥431m | at 2025-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥394m | at 2024-12-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥431m | at 2025-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥394m | at 2024-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥350m | at 2024-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥357m | at 2023-12-31v | Standalone | Cash and cash equivalents |
| Operating cash flow | ¥104m | 2025-01-01 → 2025-06-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥195m | 2024-01-01 → 2024-12-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥99m | 2024-01-01 → 2024-06-30 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥41m | 2025-01-01 → 2025-06-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥599m | 2024-01-01 → 2024-12-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥14m | 2024-01-01 → 2024-06-30 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | −¥26m | 2025-01-01 → 2025-06-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥285m | 2024-01-01 → 2024-12-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥92m | 2024-01-01 → 2024-06-30 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥66.11 | 2025-01-01 → 2025-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-17.56 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.95 | 2024-01-01 → 2024-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥65.29 | 2025-01-01 → 2025-06-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥18.64 | 2024-01-01 → 2024-06-30 | Standalone | Diluted earnings per share (5-year summary) |
| Equity ratio | 49.0% | at 2025-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.0% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.5% | at 2024-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 941,700 | at 2025-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 941,700 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 941,700 | at 2024-06-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 12
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E36431-000Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥107m |
| jpcrp040300-q2r_E36431-000Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥107m |
| jpcrp040300-q2r_E36431-000Media Business For Pregnancy Childbirth And Childcarereportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥813m |
| jpcrp040300-q2r_E36431-000Media Business For Pregnancy Childbirth And Childcarereportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥813m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-01-01 → 2025-06-30 | ¥920m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-01-01 → 2025-06-30 | ¥920m |
| jpcrp040300-q2r_E36431-000Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥146m |
| jpcrp040300-q2r_E36431-000Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥146m |
| jpcrp040300-q2r_E36431-000Media Business For Pregnancy Childbirth And Childcarereportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥589m |
| jpcrp040300-q2r_E36431-000Media Business For Pregnancy Childbirth And Childcarereportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥589m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-01-01 → 2024-06-30 | ¥735m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-01-01 → 2024-06-30 | ¥735m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 416
| Item | Context | Value | Unit |
|---|---|---|---|
| Year to quarter end statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Quarterly statement of cash flows (text) | CurrentYTDDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1YTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes segment information etc quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Description of nature of differences between profit loss of reportable segments total and quarterly financial statements (text) | Prior1YTDDuration_NonConsolidatedMember | Text · Plus | |
| Description of nature of differences between profit loss of reportable segments total and quarterly financial statements (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes revenue recognition quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |